Advances in the Discovery of Retinal Degeneration

Dear Colleagues,

Recent years have seen significant advancements in the understanding and treatment of retinal degeneration, a group of conditions leading to progressive vision loss and blindness. The field has evolved rapidly, driven by groundbreaking discoveries in genetic research, novel imaging techniques and innovative therapeutic approaches.

High-throughput sequencing technologies and genome-wide association studies have enabled researchers to pinpoint the specific genes and pathways involved in these disorders, offering new targets for therapeutic intervention. Pharmacological approaches targeting the molecular pathways implicated in retinal degeneration have also made strides. Drugs designed to modulate oxidative stress, inflammation and apoptosis are currently being explored, with some showing promising results in preclinical and early clinical studies.

Given these significant advances, the field of retinal degeneration is ripe for further research and discovery. We invite scientists to contribute their cutting-edge research to our journal's Special Issue, providing a platform to share their findings and drive the next wave of innovation in understanding and treating retinal degeneration. Your contributions will not only enrich the scientific community, but also pave the way for improved therapeutic options for patients suffering from these debilitating conditions.

Dr. Ram Prasad
Dr. Yvonne Adu-Rutledge
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.